Droperidol
Back to searchMolecule Structure
Scientific Name
Droperidol
Description of the Drug
Droperidol is a butyrophenone derivative and dopamine antagonist used to prevent and treat postoperative nausea and vomiting.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00450
http://www.drugbank.ca/drugs/DB00450
Brand Name(s)
Dridol, Droleptan, Droperidol, Inapsine
Company Owner(s)
Igi Laboratories Inc, Luitpold Pharmaceuticals Inc, Solopak Laboratories Inc, Hospira Inc, Watson Laboratories Inc, Smith And Nephew Solopak Div Smith And Nephew, Abraxis Pharmaceutical Products, American Regent Inc, Eurohealth International Sarl, Akorn Operating Co Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| D2-like dopamine receptor | PROTEIN FAMILY | ANTAGONIST | CHEMBL2331075 |
| Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL41426 |
| PharmGKB | PA449422 |
| Human Metabolome Database | HMDB0014593 |
| DrugBank | DB00450 |
| PubChem: Thomson Pharma | 14780048 |
| PubChem | 3168 |
| LINCS | LSM-4193 |
| Nikkaji | J26.622A |
| PDBe | USS |
| BindingDB | 50017705 |
| EPA CompTox Dashboard | DTXSID6022973 |
| DrugCentral | 966 |
| Brenda | 217393 |
| ChemicalBook | CB9145418 |
| Guide to Pharmacology | 7172 |
| rxnorm | DROPERIDOL |
| ChEBI | 4717 |
| ZINC | ZINC000019796080 |
